You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-UHRF1 antibodySee all UHRF1 primary antibodies ...
  • Description
    Mouse monoclonal to UHRF1
  • Tested applicationsWB, IHC-P, ICC/IF, Flow Cyt more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant fragment: WNEVLASLKD RPASGSPFQL FLSKVEETFQ CICCQELVFR PITTVCQHNV CKDCLDRSFR AQVFSCPACR YDLGRSYAMQ VNQPLQTVLN QLFPGYGNGR , corresponding to amino acids 694-794 of Human UHRF1

Properties

Applications

Our Abpromise guarantee covers the use of ab57083 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use a concentration of 1 - 5 µg/ml. Predicted molecular weight: 90 kDa.
IHC-P IHC-P: Use a concentration of 3 µg/ml.
ICC/IF ICC/IF: Use a concentration of 5 µg/ml.
Flow Cyt Flow Cyt: Use 1µg for 106 cells.

Target

  • FunctionPutative E3 ubiquitin-protein ligase. May participate in methylation-dependent transcriptional regulation. Binds to inverted 5'-CCAAT-3' box 2 in the TOP2A promoter, and activates TOP2A expression. Important for G1/S transition. May be involved in DNA repair and chromosomal stability.
  • Tissue specificityExpressed in thymus, bone marrow, testis, lung and heart. Overexpressed in breast cancer.
  • PathwayProtein modification; protein ubiquitination.
  • Sequence similaritiesContains 1 PHD-type zinc finger.
    Contains 2 RING-type zinc fingers.
    Contains 1 ubiquitin-like domain.
    Contains 1 YDG domain.
  • Developmental stageExpressed in fetal thymus, liver and kidney.
  • DomainThe RING finger is required for ubiquitin ligase activity.
    The YDG domain mediates the interaction with histone H3.
  • Post-translational
    modifications
    Phosphorylated on serine residues. Phosphorylation may enhance DNA-binding activity.
    Ubiquitinated; which leads to proteasomal degradation. Polyubiquitination may be stimulated by DNA damage.
  • Cellular localizationNucleus.
  • Target information above from: UniProt accession Q96T88 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Ac2-121 antibodyAL022808 antibodyE3 ubiquitin-protein ligase UHRF1 antibody
      EC 6.3.2.- antibodyFLJ21925 antibodyhNP95 antibodyhUHRF1 antibodyHuNp95 antibodyICBP90 antibodyInverted CCAAT box binding protein of 90 kDa antibodyInverted CCAAT box binding protein, 90-kD antibodyInverted CCAAT box-binding protein of 90 kDa antibodyLiver regeneration-related protein LRRG126 antibodyMGC138707 antibodyNP95 antibodyNuclear phosphoprotein, 95-KD antibodyNuclear protein 95 antibodyNuclear zinc finger protein Np95 antibodyRING finger protein 106 antibodyRNF106 antibodyTranscription factor ICBP90 antibodyUbiquitin like containing PHD and RING finger domains protein 1 antibodyUbiquitin like PHD and RING finger domain containing protein 1 antibodyUbiquitin-like PHD and RING finger domain-containing protein 1 antibodyUbiquitin-like protein containing PHD and RING finger domains 1 antibodyUbiquitin-like with PHD and ring finger domains 1 antibodyUbiquitin-like, containing PHD and RING finger domains, 1 antibodyUbiquitin-like-containing PHD and RING finger domains protein 1 antibodyUHRF1 antibodyUHRF1_HUMAN antibody
    see all

Anti-UHRF1 antibody images

  • UHRF1 antibody (ab57083) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human endometrium.


  • Predicted band size : 90 kDa
    UHRF1 antibody (ab57083) at 1ug/lane + HeLa cell lysate at 25ug/lane.
  • ICC/IF image of ab57083 stained HepG2 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab57083, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  • Overlay histogram showing MCF7 cells stained with ab57083 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab57083, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

References for Anti-UHRF1 antibody (ab57083)

This product has been referenced in:
  • Wang F  et al. UHRF1 Promotes Cell Growth and Metastasis Through Repression of p16(ink4a) in Colorectal Cancer. Ann Surg Oncol : (2012). Read more (PubMed: 22219067) »
  • Rothbart SB  et al. Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat Struct Mol Biol 19:1155-60 (2012). WB . Read more (PubMed: 23022729) »

See all 3 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab57083.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"